Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

URGNURGN
Showing 8 of 15 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in UROGEN PHARMA LTD

TWO SIGMA INVESTMENTS, LP holds 148,963 shares of URGN (UROGEN PHARMA LTD), worth $5.5M as of 2026-Q2. The position was decreased (-16.3% shares). URGN represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$5.5M

Current Shares

148,963

Total Value Change

+$4.4M

Total Shares Change

+61,929

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
148,963
-16.3%
$5.5M0.0%$36.80
0
2026-Q1
Decreased
177,901
-26.3%
$3.2M0.0%$18.82
0
2025-Q4
Decreased
241,213
-37.5%
$5.6M0.0%$23.17
0
2025-Q3
Increased
386,203
+103.9%
$7.7M0.0%$19.14
44
2025-Q2
Increased
189,412
+995.6%
$2.6M0.0%$13.49
42
2025-Q1
Decreased
17,288
-69.6%
$191,2050.0%$11.20
0
2024-Q4
Decreased
56,895
-34.6%
$605,9320.0%$10.52
0
2024-Q3
Decreased
87,034
-13.3%
$1.1M0.0%$12.90
0

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used